Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions.

doi:10.1016/j.bmc.2015.03.071

Paper

DOI: 10.1016/j.bmc.2015.03.071

Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions.

Published Jul 1, 2015 · Navriti Chadha, M. S. Bahia, Maninder Kaur

Bioorganic & medicinal chemistry

Q2 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

Thiazolidine-2,4-dione derivatives show potential as therapeutic agents for various diseases by improving protein binding interactions and gaining knowledge of molecular interactions.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1016/j.ejmech.2014.09.010

Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.

Novel oxadiazole-based thiazolidine-2,4-diones bis-heterocycles show potential as new antidiabetic agents with comparable blood glucose lowering effects to standard drugs Pioglitazone and Rosiglitazone without causing weight gain or he

2014·52citations·Syed Nazreen et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

DOI: 10.1016/j.bmcl.2014.05.034

Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.

Compounds 5c and 5e show promising potential as new antidiabetic agents with comparable blood glucose lowering effects to pioglitazone and no liver damage.

2014·45citations·Syed Nazreen et al.·Bioorganic & medicinal chemistry letters

Bioorganic & medicinal chemistry letters

DOI: 10.1097/01.NAJ.0000443797.94461.AB

Hydrocodone: A New Recommendation And A New Drug

The FDA recommends reclassifying hydrocodone-containing drugs as schedule II controlled substances, and has approved Zohydro ER, an extended-release form, for treating severe and chronic pain.

2014·1citation·D. Aschenbrenner·American Journal of Nursing

American Journal of Nursing

DOI: 10.1016/j.ejmech.2013.10.078

Studies on the synthetic and structural aspects of benzosuberones bearing 2, 4-thiazolidenone moiety as potential anti-cancer agents.

Compounds 6a and 6g show promising cytotoxicity against various cancer cell lines, with compound 6g showing potent cytotoxicity against human breast adenocarcinoma cell line MCF-7.

2014·40citations·L. Nagarapu et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

DOI: 10.1016/j.febslet.2013.09.031

Inhibitor selectivity between aldo–keto reductase superfamily members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)

AKR1B10 inhibitors can retain binding affinities by inducing Trp112 flip, while selective AKR1B10 inhibitors can take advantage of the broader active site provided by the native Trp112 side-chain orientation.

2013·78citations·Liping Zhang et al.·FEBS Letters

FEBS Letters

DOI: 10.1155/2013/926060

Synthesis of a Novel Thiazolidinedione and Evaluation of Its Modulatory Effect on IFN-γ, IL-6, IL-17A, and IL-22 Production in PBMCs from Rheumatoid Arthritis Patients

TM17 shows potential as a promising RA treatment by significantly reducing IL-17A, IL-22, and IFN- levels while increasing PPAR mRNA expression without stimulus.

2013·26citations·L. F. da Rocha Júnior et al.·BioMed Research International

BioMed Research International

DOI: 10.1007/s12272-013-0184-5

Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor

MHY498 is a potent tyrosinase inhibitor with potential as an anti-melanogenic agent for prevention and treatment of skin pigmentation diseases.

2013·34citations·So H. Kim et al.·Archives of Pharmacal Research

Archives of Pharmacal Research

DOI: 10.1016/j.ejmech.2013.05.044

Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones

The synthesized compounds show promising anticancer activity against leukemia, with derivatives 4d and 4f showing promising antitrypanosomal and antiviral effects.

2013·85citations·D. Havrylyuk et al.·European Journal of Medicinal Chemistry

European Journal of Medicinal Chemistry

DOI: 10.1016/j.ejmech.2012.10.044

2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents.

Hydantoin derivatives with 6-bromo-2-methyl-2H-chromene substructure show the best cytotoxicity profile, comparable to cisplatin, as potential anticancer agents.

2013·175citations·Mohammad Azizmohammadi et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

Citations

DOI: 10.1016/j.phytol.2024.09.001

Multi-target anticancer activity of compounds isolated from galls of Pistacia chinensis subsp. integerrima: A mechanistic investigation

Spinacetin, a flavonoid found in Pistacia chinensis subsp. integerrima galls, shows potential as a multi-target anticancer agent by targeting metabolism-related enzymes and angiogenesis-related proteins.

2024·0citations·Abdur Rauf et al.·Phytochemistry Letters

Phytochemistry Letters

DOI: 10.30574/gscbps.2024.29.2.0411

RP-HPLC method for the estimation of Lobeglitazone sulphate in pharmaceutical dosage form

This study developed and validated a simple, rapid, accurate, and precise RP-HPLC method for determining Lobeglitazone sulfate in tablet dosage form, meeting ICH guidelines.

2024·0citations·Ravinder Bairam et al.·GSC Biological and Pharmaceutical Sciences

GSC Biological and Pharmaceutical Sciences

DOI: 10.1002/jhet.4918

Coumarin Derivatives: Microwave Synthesis and Biological Properties—A Review

Microwave synthesis of coumarin derivatives reduces toxic chemicals and improves yield, purity, and energy consumption while maintaining their biological activities.

2024·0citations·Wissam Habibi et al.·Journal of Heterocyclic Chemistry

Journal of Heterocyclic Chemistry

DOI: 10.1002/slct.202403497

2‐Chloroquinolinyl‐thiazolidine‐2,4‐dione Hybrids as Potential α‐Amylase Inhibitors: Synthesis, Biological Evaluations, and In Silico Studies

New 2chloroquinolinyl-thiazolidine-2,4-dione hybrids show potential as amylase inhibitors, with compound 15n showing the most potent inhibition of amylase with 95% inhibition.

2024·0citations·Sheetal B. Karmur et al.·ChemistrySelect

ChemistrySelect

DOI: 10.1002/open.202400147

Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements

Recent advances in medicinal chemistry have unveiled diverse therapeutic potentials of 2,4-thiazolidinedione derivatives, including anticancer, antimicrobial, anti-inflammatory, antioxidant, and anticonvulsant activities, while mitigating side effects in type 2 diabetes management.

2024·0citations·Sneha Gupta et al.·ChemistryOpen

ChemistryOpen

DOI: 10.3390/antiox13080898

Multitarget Pharmacology of Sulfur–Nitrogen Heterocycles: Anticancer and Antioxidant Perspectives

Sulfur-nitrogen heterocycles show potential as dual antioxidant and anticancer drugs, potentially enhancing therapeutic efficacy in oncology by targeting multiple pathways.

2024·3citations·Aliki Drakontaeidi et al.·Antioxidants

Antioxidants